RhoGDI, which is higher in the healthy heart than the feline HCM heart, inhibits the family of Rho GTPases which drive inflammation, fibrosis, and vascular remodeling in cardiac hypertrophy [61]. The gene discussed is ARHGDIA; the disease is cardiac hypertrophy.